Press Releases Phastar Scoops Multiple Finalist Positions in 2025 Scrip Awards October 1st, 2025 3 minute read Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as fi...
Press Releases Phastar Appoints Industry Veteran Billy Amzal as Head of Strategic Consulting June 24th, 2025 2 minute read London, UK, and Durham (NC), US – June 24th, 2025: Phastar, a global specialist biometrics & data science Contrac...
Press Releases Phastar Secures Finalist Spot at 2025 Citeline Awards April 10th, 2025 3 minute read London, UK, and Durham (NC), US – April 10th, 2025: Phastar, a global specialist biometrics & data science Contra...
Events Meet Phastar at ACDM 2026 October 13th, 2025 1 minute read Phastar is delighted to be exhibiting at ACDM in Berlin from 15th – 17th March. Visit the Phastar team and find...
Events Meet Phastar at Biostatistics Symposium of Southern California 2026 October 13th, 2025 1 minute read Phastar is delighted to be a Bronze Sponsor at the upcoming BSSC Conference in Foster City, CA. Meet with our experts...
Events Meet Phastar at Summit for Clinical Operations Executives (SCOPE) 2026 October 13th, 2025 1 minute read Phastar is delighted to be exhibiting at SCOPE 2026, the premier event for clinical operations and innovation. From F...
Webinars Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls November 5th, 2025 1 minute read Use of external data to augment clinical trials has been increasingly evaluated and is transforming drug development ...
Webinars Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines October 30th, 2025 1 minute read The early stages of clinical development are critical, decisions made here can determine the efficiency, cost, and ul...
Webinars Use of Real-World Data for in-silico Trials and Innovative Designs: Recent Successes and Current Perspectives October 2nd, 2025 1 minute read Real-world data (RWD) are transforming clinical research. By supplementing randomized controlled trials (RCTs), RWD c...
Case Studies Delivering an Integrated Summary of Safety: Resolving Data Inconsistencies and Complex Derivations to Support Regulatory Submission October 22nd, 2025 1 minute read Phastar supported a sponsor in preparing an Integrated Summary of Safety (ISS) for an investigational drug in sickle ...
Case Studies Delivering a Large-Scale Integrated Summary of Safety: Standardizing 30 Studies Across Multiple Phases and Indications October 22nd, 2025 2 minute read Phastar supported a sponsor in preparing an Integrated Summary of Safety (ISS) for an investigational product in faci...
Case Studies IDAC for Interim Analysis of a Phase III Study in Essential Tremor: Ensuring Precision Amid Shifting Priorities October 17th, 2025 1 minute read Interim analyses in Phase III trials are high-stakes and often come with evolving requirements and tight timelines. W...
Articles & Interviews Utilizing Tech Tools to Accelerate Drug Development November 6th, 2025 1 minute read The adoption of advanced technological tools in clinical trials is accelerating as sponsors seek faster insights, str...
Articles & Interviews Specialist Data-Focused CROs: The Partnership Solution for Modern Clinical Trials August 27th, 2025 1 minute read Outsourcing clinical trial activities to specialist data-focused CROs is growing rapidly, driven by the need for expe...
Articles & Interviews A Conversation with Billy Amzal: Phastar’s new Head of Strategic Consulting August 21st, 2025 1 minute read In this exclusive interview for World Pharma Today, Phastar’s Head of Strategic Consulting, Billy Amzal, shares his c...
Blogs Meet the Team: Alice Spencer, Senior Statistician November 6th, 2025 3 minute read In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each te...
Blogs The Need for a DMC and the Operational Role of an Independent Data Analysis Center: Practical Insights for Sponsors November 4th, 2025 5 minute read Introduction Data Monitoring Committees (DMCs) play a pivotal role in protecting the rights, safety and well-being o...
Blogs The Rise of Innovative Trial Designs in Rare Disease Research October 28th, 2025 6 minute read By Billy Amzal, Head of Strategic Consulting, Phastar Introduction Rare disease research demands tailored...
Publications Advancing Clinical Trial Design with Bayesian Statistics and Prior Elicitation April 1st, 2025 1 minute read Discover how Bayesian statistics can enhance clinical trial efficiency and improve decision-making. Our latest white ...
Publications Unlock the Power of Real-World Evidence in Clinical Research February 25th, 2025 1 minute read Discover how Real-World Evidence (RWE) is revolutionizing drug development and clinical decision-making in our latest...
Publications A Strategic Approach to Project Optimus: Key Considerations for Oncology Trials October 10th, 2024 1 minute read As oncology drug development continues to evolve, the FDA’s Project Optimus is reshaping how clinical trials ap...
